|
⚲
|
| Calistoga Pharmaceuticals Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001385313 |
| Sale | 2009-05-01 ($31.0 M Offered, $15.0 M Sold) |
| Fund | |
| Phone | 2067284700 |
| Address | 2101 Fourth Avenue Seattle, 98121 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2026 |
|---|---|
| Robert Douglas | |
| James Topper | |
| Ed Hurwitz | |
| W Michael Gallatin | |
| Richard Lin | |
| Aaron Coe | |
| Carol Gallagher |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
AQR Flex 1 Series LLC - Series A9
✚
|
0.0 | |
|
AQR Flex 1 Series LLC - Series C3
✚
|
0.0 | |
|
AQR Flex 1 Series LLC - Series E1
✚
|
0.0 | |
|
Aralis James
✚
|
0.0 | |
|
Arbor Realty Trust Inc
✚
|
0.0 | |
|
Arcade AI Inc
✚
|
0.0 | |
|
ARCH Venture Fund XIII, L.P.
✚
|
0.0 | |
|
ARCH Venture Fund XII, L.P.
✚
|
0.0 | |
|
ARCH Venture Fund X, L.P.
✚
|
0.0 | |
|
AQR Flex 1 Series LLC - Series A8
✚
|
0.0 |